Author:
Nüssler V.,Pelka-Fleischer R.,Zwierzina H.,Nerl C.,Beckert B.,Gieseler F.,Hölzel D.,Ledderose G.,Gullis E.,Sauer H.,Wilmanns W.
Publisher
Springer Berlin Heidelberg
Reference73 articles.
1. Büchner T, Hiddemann W, Koch P, Pielken H, Urbanitz D, Kreutzmann H, Maschmeyer G, Wendt F, Kuse R, Thiel E, Ludwig W.D, Seibt H, Gassmann W, Löffler H, Aul C, Heyll A, Schneider W, Mertelsmann R, Anders C.H, Nowrousian M.R, Straif K, Vaupel H.A, Hossfeld D: The role of maintenance chemotherapy, immunotherapy, induction dose reduction in elderly patients and double induction in the treatment of adult acute myeloid leukemia. 4 randomized studies of the AML Cooperative Group. Neue therapeutische Strategien in der hämatologischen Onkologie. 36: 1, 1989
2. Büchner T, Hiddemann W, Maschmeyer G, Ludwig W, Löffler H, Nowrousian M, Aul C, Heinecke A: How to improve therapy for adult acute myeloid leukemia. Studies of the AMLCooperative-Group in the Federal Republic of Germany J. Cancer Res. clin. Oncol. 116: 97, 1990.
3. Jehn U, Zittoun R, Suciu S, Fiere D, Haanen C, Peetermans M, Löwenberg B, Willemze R, Solbu G, Stryckmans P, EORTC Leukemia Cooperative Group: A randomized comparison of intensive maintenance treatment for adult acute myelogenous leukemia using either cyclic alternating drugs or repeated courses of the induction-type chemotherapy. AML-6 trial of the EORTC Leukemia Cooperative Group. Hemat. Blood Transfusion. 33:277, 1990
4. Thiel E, Kranz B.R. Raghavachar A, Bartram CR, Löffler H, Messerer D, Ganser A, Ludwig W.D. Büchner T, Hölzer D: Prethymic phenotype and genotype of pre-T (CD7–/ER-) cell leukemia and its clinical significance within adult acute lymphoblastic leukemia. Blood. 37: 1247, 1989
5. Hölzer D, Thiel E, Löffler H, Büchner T, Ganser A: Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood 71: 123, 1988